Tivic Health Systems, Inc., today announced it has acquired worldwide exclusive license rights from Statera Biopharma to the late-stage Toll-like Receptor 5 (TLR5) agonist Entolimodtm for the ...
With Fevertree still priced at growth stock valuations, it pays to be cautious.
NanoXplore Inc. ("NanoXplore" or "the Corporation") , a world-leading graphene company, reported today financial results for the three-month and six-month periods ended December 31, 2024. All amounts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback